Diligence memo · auto-generated · as of July 2, 2026
Calyxo, Inc.
Calyxo, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Calyxo, Inc. operates in Other Health Care, based in PLEASANTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Calyxo, Inc. has raised $116M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $50M on 2023-10-27.
Most recent recorded round closed around 2024-12-20.
Valuation (modeled)modeled
Provath models Calyxo, Inc. at approximately $205M (range $103M–$292M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.31× the median modeled value of Series C Other Health Care companies in 2022–2024 (47 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 18 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 1.8× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 97% of Other Health Care peers (5377 compared).
Modeled value ranks above 88% of those peers.
Closest niche peers: Gravie, Inc., EmpowerMe Holdings, LLC, Color Holdings, L.P., RSR Senior Residences, LLC, Gynesonics, Inc.
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.